Clinical trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy
NCT00891683 is registered in ClinicalTrials.gov with Aegera Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy
- Lead sponsor
- Aegera Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- February 28, 2010
- Enrollment
- 128 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, diabetic peripheral neuropathy